Testemianu Introduction: Hodgkin lymphoma is a malignant tumor of the lymphatic system. Hodgkins disease occurs predominantly in young adults and is one of the most curable malignancies. With current treatment approaches, most patients achieve a lasting complete remission, but there is a high risk of developing in these patients secondary malignant tumors, and the mortality is associated with both radiotherapy and chemotherapy.
Purpose and Objectives: Researching metachronous malignancies in patients with Hodgkin lymphoma and studying the frequency of their occurance, depending of the age, sex, clinical stages, histological forms, the administrated treatment for Hodgkin lymphoma and also the time period for developing secondary malignancies. Materials and Methods: Our study is based on 53 pacients diagnosed and treated for Hodgkin Lymphoma in Oncological Institute of Republic of Moldova, all the pacients where cancer treatment hodgkins lymphoma complete remision when they developed secondary malignancy.
In our cancer treatment hodgkins lymphoma were involved 22 men and 31 women, with ages between 4 and 81 years.
Our research carried out that there is a prevalence of a cancer treatment hodgkins lymphoma chemo-radiotherapy method of treatment Conclusions: After treatment for Hodgkin's lymphoma in patients may develop secondary metachronous tumors, that occur more frequently in women aged years at diagnosis of Hodgkin lymphoma.
Metachronous secondary tumors are identified mainly in patients diagnosed with stage IIA Hodgkin lymphoma, histological variant most commonly diagnosed as mixed cellularity.
The method of treatment was chosen for the majority of patients was chemo-radiotherapeutic. Period of development of secondary tumors is years after treatment for Hodgkin's lymphoma.
Secondary malignancies after Hodgkin Lymphoma can have different location. Keywords: Hodgkin Lymphoma, secondary metachronous tumors Related Interests.